|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
GB0121980D0
(en)
*
|
2001-09-11 |
2001-10-31 |
Cathnet Science Holding As |
Expandable stent
|
|
US7892273B2
(en)
|
2001-12-03 |
2011-02-22 |
Xtent, Inc. |
Custom length stent apparatus
|
|
US7137993B2
(en)
|
2001-12-03 |
2006-11-21 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
|
US7147656B2
(en)
|
2001-12-03 |
2006-12-12 |
Xtent, Inc. |
Apparatus and methods for delivery of braided prostheses
|
|
US20030135266A1
(en)
|
2001-12-03 |
2003-07-17 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
|
US7351255B2
(en)
|
2001-12-03 |
2008-04-01 |
Xtent, Inc. |
Stent delivery apparatus and method
|
|
US7309350B2
(en)
|
2001-12-03 |
2007-12-18 |
Xtent, Inc. |
Apparatus and methods for deployment of vascular prostheses
|
|
US7182779B2
(en)
|
2001-12-03 |
2007-02-27 |
Xtent, Inc. |
Apparatus and methods for positioning prostheses for deployment from a catheter
|
|
AU2003219922B2
(en)
|
2002-02-27 |
2009-09-10 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
JP2007505932A
(ja)
*
|
2003-09-18 |
2007-03-15 |
マクサイト， インコーポレイテッド |
経強膜送達
|
|
US7326236B2
(en)
|
2003-12-23 |
2008-02-05 |
Xtent, Inc. |
Devices and methods for controlling and indicating the length of an interventional element
|
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
US8562505B2
(en)
|
2004-02-20 |
2013-10-22 |
The Children's Hospital Of Philadelphia |
Uniform field magnetization and targeting of therapeutic formulations
|
|
US9028829B2
(en)
*
|
2004-02-20 |
2015-05-12 |
The Children's Hospital Of Philadelphia |
Uniform field magnetization and targeting of therapeutic formulations
|
|
US7846201B2
(en)
*
|
2004-02-20 |
2010-12-07 |
The Children's Hospital Of Philadelphia |
Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex
|
|
US7323006B2
(en)
|
2004-03-30 |
2008-01-29 |
Xtent, Inc. |
Rapid exchange interventional devices and methods
|
|
US8317859B2
(en)
|
2004-06-28 |
2012-11-27 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
|
US20050288766A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Xtent, Inc. |
Devices and methods for controlling expandable prostheses during deployment
|
|
WO2006080951A2
(en)
*
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
WO2006023207A2
(en)
*
|
2004-08-19 |
2006-03-02 |
The United States Of America As Represented By The Secretary Of Health And Human Services, Nih |
Coacervate of anionic and cationic polymer forming microparticles for the sustained release of therapeutic agents
|
|
AU2005279960A1
(en)
*
|
2004-08-30 |
2006-03-09 |
Neville Alleyne |
Method of using an implant for treatment of ligaments and tendons
|
|
JP2008511420A
(ja)
|
2004-08-30 |
2008-04-17 |
スピネオベイションズ・インコポレーテッド |
脊髄の椎間板内障害の治療の方法
|
|
US7985426B1
(en)
*
|
2004-10-05 |
2011-07-26 |
Hsing-Wen Sung |
Nanoparticles for targeting hepatoma cells and delivery means
|
|
WO2007001448A2
(en)
*
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
CA2597590A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
US9205046B2
(en)
*
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Enhanced stability of inverse thermal gelling composite hydrogels
|
|
US20070248675A1
(en)
*
|
2005-09-08 |
2007-10-25 |
Gwangju Institute Of Science And Technology |
Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
KR101529318B1
(ko)
|
2005-12-19 |
2015-06-16 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법
|
|
BRPI0600285C1
(pt)
*
|
2006-01-13 |
2011-10-11 |
Brz Biotecnologia Ltda |
compostos farmacêuticos contendo nanopartìculas úteis para tratamento de lesões reestenóticas
|
|
CN101008643B
(zh)
*
|
2006-01-23 |
2013-03-27 |
中国人民解放军军事医学科学院生物医学分析中心 |
一种金属螯合纳米磁珠,其制备方法及应用
|
|
KR101478164B1
(ko)
|
2006-02-09 |
2014-12-31 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
WO2007109621A2
(en)
|
2006-03-20 |
2007-09-27 |
Xtent, Inc. |
Apparatus and methods for deployment of linked prosthetic segments
|
|
AU2007230964B2
(en)
|
2006-03-23 |
2012-07-19 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
WO2008105773A2
(en)
|
2006-03-31 |
2008-09-04 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
|
US20070281034A1
(en)
*
|
2006-05-15 |
2007-12-06 |
Kirpotin Dmitri B |
Magnetic microparticles comprising organic substances
|
|
US8367113B2
(en)
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
WO2007137117A2
(en)
*
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
|
EP2032149A4
(en)
*
|
2006-06-13 |
2010-09-01 |
Fmc Biopolymer As |
METHOD AND SYSTEMS FOR THE USE OF BIOPOLYMER-BASED BEADS AND HYDROGELS
|
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
US20100144845A1
(en)
*
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
JP2010502713A
(ja)
*
|
2006-09-08 |
2010-01-28 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
粘液を通る輸送を増強するための組成物および方法
|
|
US8563022B2
(en)
*
|
2006-10-11 |
2013-10-22 |
Board Of Regents Of The University Of Texas System |
Particles for cell targeting
|
|
CA2668130A1
(en)
*
|
2006-11-03 |
2008-06-05 |
Boston Scientific Limited |
Stents with drug eluting coatings
|
|
US20080107744A1
(en)
*
|
2006-11-06 |
2008-05-08 |
Jack Fa-De Chu |
Injectable hollow tissue filler
|
|
CN101646417B
(zh)
*
|
2006-11-16 |
2015-11-25 |
阿克伦大学 |
将遗传物质引入活细胞的材料和方法
|
|
US20100303723A1
(en)
*
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
US8551139B2
(en)
|
2006-11-30 |
2013-10-08 |
Cook Medical Technologies Llc |
Visceral anchors for purse-string closure of perforations
|
|
US20080146489A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Pacetti Stephen D |
Regional delivery of therapeutic agents for the treatment of vascular diseases
|
|
US7850382B2
(en)
*
|
2007-01-18 |
2010-12-14 |
Sanford, L.P. |
Valve made from two materials and writing utensil with retractable tip incorporating same
|
|
US7488130B2
(en)
|
2007-02-01 |
2009-02-10 |
Sanford, L.P. |
Seal assembly for retractable instrument
|
|
US9217129B2
(en)
*
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
US10265407B2
(en)
|
2007-02-15 |
2019-04-23 |
Yale University |
Modular nanodevices for smart adaptable vaccines
|
|
WO2008115641A2
(en)
*
|
2007-02-15 |
2008-09-25 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
|
US20080199510A1
(en)
|
2007-02-20 |
2008-08-21 |
Xtent, Inc. |
Thermo-mechanically controlled implants and methods of use
|
|
WO2008109347A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Yale University |
Methods for ex vivo administration of drugs to grafts using polymeric nanoparticles
|
|
JP5650406B2
(ja)
|
2007-03-07 |
2015-01-07 |
ユーティーアイ リミテッド パートナーシップ |
自己免疫状態の予防および治療のための組成物および方法
|
|
US8486132B2
(en)
|
2007-03-22 |
2013-07-16 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
|
US20090074828A1
(en)
|
2007-04-04 |
2009-03-19 |
Massachusetts Institute Of Technology |
Poly(amino acid) targeting moieties
|
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
|
AU2008240155B2
(en)
*
|
2007-04-13 |
2012-09-20 |
University Of North Texas Health Science Center At Fort Worth |
Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics
|
|
US20100290982A1
(en)
*
|
2007-04-13 |
2010-11-18 |
University Of North Texas Health Science Center At Fort Worth |
Solid in oil/water emulsion-diffusion-evaporation formulation for preparing curcumin-loaded plga nanoparticles
|
|
US9044385B2
(en)
*
|
2007-05-16 |
2015-06-02 |
Abbott Cardiovascular Systems Inc. |
Therapeutic compositions for targeted vessel delivery
|
|
US8889140B2
(en)
*
|
2007-05-31 |
2014-11-18 |
Transtarget, Inc. |
Compositions and methods for tissue repair
|
|
US8740937B2
(en)
*
|
2007-05-31 |
2014-06-03 |
Cook Medical Technologies Llc |
Suture lock
|
|
US20080299172A1
(en)
*
|
2007-06-04 |
2008-12-04 |
Stuart Young |
Tissue repair implant
|
|
US7901452B2
(en)
*
|
2007-06-27 |
2011-03-08 |
Abbott Cardiovascular Systems Inc. |
Method to fabricate a stent having selected morphology to reduce restenosis
|
|
DE102007030931A1
(de)
*
|
2007-07-03 |
2009-01-08 |
Birgit Riesinger |
Zusammensetzung, enthaltend mindestens einen nutritiven, mindestens einen desinfizierenden bzw. dekontaminierenden und/oder mindestens einen Proteasen hemmend wirkenden Wirkstoff und/oder Wirkstoffkomplex
|
|
WO2009010071A1
(en)
*
|
2007-07-16 |
2009-01-22 |
Aarhus Universitet |
Osteopontin nanoparticles system for drug delivery
|
|
US20110092446A1
(en)
*
|
2007-07-20 |
2011-04-21 |
Cedric Francois |
Compositions and methods for treatment of trauma
|
|
AU2008279309B2
(en)
*
|
2007-07-23 |
2013-10-31 |
The University Of Akron |
Metal complexes incorporated within biodegradable nanoparticles and their use
|
|
US7960336B2
(en)
*
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
*
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
US9173890B2
(en)
*
|
2007-09-20 |
2015-11-03 |
Abbott Cardiovascular Systems Inc. |
Sustained release of Apo A-I mimetic peptides and methods of treatment
|
|
WO2009042598A1
(en)
*
|
2007-09-25 |
2009-04-02 |
Wilson-Cook Medical Inc. |
Medical devices, systems, and methods for using tissue anchors
|
|
ATE530169T1
(de)
*
|
2007-09-28 |
2011-11-15 |
Bind Biosciences Inc |
Krebszellen-targeting mit nanopartikeln
|
|
MX2010003642A
(es)
|
2007-10-12 |
2010-08-09 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
|
WO2009050696A2
(en)
*
|
2007-10-18 |
2009-04-23 |
Qray Ltd. |
Composition and method for cell activation and tissue repair using nanoparticles and light
|
|
GB0721081D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Metcalfe Susan M |
Immuno-modulatory composition
|
|
US20090156459A1
(en)
*
|
2007-11-16 |
2009-06-18 |
Pharmain Corporation |
Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
US20090157099A1
(en)
*
|
2007-12-18 |
2009-06-18 |
Wilson-Cook Medical, Inc. |
Device and method for placement of tissue anchors
|
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
AU2009207287B2
(en)
*
|
2008-01-25 |
2014-09-11 |
Gavish-Galilee Bio Applications Ltd |
Targeting of innate immune response to tumor site
|
|
US8469961B2
(en)
*
|
2008-03-05 |
2013-06-25 |
Neville Alleyne |
Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
|
|
US20100004700A1
(en)
*
|
2008-03-05 |
2010-01-07 |
Neville Alleyne |
Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres
|
|
US9101503B2
(en)
|
2008-03-06 |
2015-08-11 |
J.W. Medical Systems Ltd. |
Apparatus having variable strut length and methods of use
|
|
US9241898B2
(en)
*
|
2008-03-11 |
2016-01-26 |
Yale University |
Compositions and methods for controlled delivery of inhibitory ribonucleic acids
|
|
US9822364B2
(en)
|
2008-03-11 |
2017-11-21 |
Yale University |
Compositions and methods for controlled delivery of inhibitory ribonucleic acids
|
|
US8226312B2
(en)
*
|
2008-03-28 |
2012-07-24 |
Sanford, L.P. |
Valve door having a force directing component and retractable instruments comprising same
|
|
WO2009121065A2
(en)
*
|
2008-03-28 |
2009-10-01 |
Apellis Ag |
Modulation and repletion/enhancement of the complement system for treatment of trauma
|
|
US9839772B2
(en)
|
2008-05-06 |
2017-12-12 |
Cook Medical Technologies Llc |
Apparatus and methods for delivering therapeutic agents
|
|
US8697098B2
(en)
|
2011-02-25 |
2014-04-15 |
South Dakota State University |
Polymer conjugated protein micelles
|
|
US8728446B2
(en)
*
|
2008-06-03 |
2014-05-20 |
I Did It, Inc. |
Oral hygiene tablets and capsules for direct oral delivery of active ingredients
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
EA020753B1
(ru)
|
2008-06-16 |
2015-01-30 |
Бинд Терапьютикс, Инк. |
Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение
|
|
AU2009268923B2
(en)
|
2008-06-16 |
2015-09-17 |
Pfizer Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
US20110105417A1
(en)
*
|
2008-06-26 |
2011-05-05 |
The Curators Of The University Of Missouri |
Drug Conjugates
|
|
WO2010017215A2
(en)
*
|
2008-08-04 |
2010-02-11 |
The Regents Of The University Of California |
Biodegradable microspheres and methods of use thereof
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8221012B2
(en)
*
|
2008-11-07 |
2012-07-17 |
Sanford, L.P. |
Retractable instruments comprising a one-piece valve door actuating assembly
|
|
WO2010059253A2
(en)
|
2008-11-24 |
2010-05-27 |
Massachusets Institute Of Technology |
Methods and compositions for localized agent delivery
|
|
EP2384149B1
(en)
*
|
2008-12-05 |
2015-12-02 |
Cook Medical Technologies LLC |
Tissue anchors for purse-string closure of perforations
|
|
WO2010068866A2
(en)
|
2008-12-12 |
2010-06-17 |
Bind Biosciences |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
EA201100765A1
(ru)
*
|
2008-12-15 |
2012-04-30 |
Бинд Биосаиэнсис |
Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств
|
|
CA2747390C
(en)
|
2008-12-23 |
2016-10-04 |
Wilson-Cook Medical Inc. |
Apparatus and methods for containing and delivering therapeutic agents
|
|
US8393814B2
(en)
*
|
2009-01-30 |
2013-03-12 |
Sanford, L.P. |
Retractable instrument having a two stage protraction/retraction sequence
|
|
JP5890182B2
(ja)
|
2009-02-12 |
2016-03-22 |
インセプト エルエルシー |
ヒドロゲルプラグによる薬物送達
|
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
|
BRPI1014854A2
(pt)
*
|
2009-03-30 |
2016-05-03 |
Cerulean Pharma Inc |
"conjugados polímero-agente, partículas, composições, e métodos de uso relacionados"
|
|
FR2943544B1
(fr)
*
|
2009-03-31 |
2012-04-20 |
Univ Angers |
Procede de preparation de capsules lipidiques fonctionnalisees.
|
|
CA2757554A1
(en)
|
2009-04-03 |
2010-10-07 |
Cook Medical Technologies Llc |
Tissue anchors and medical devices for rapid deployment of tissue anchors
|
|
US8382776B2
(en)
*
|
2009-04-03 |
2013-02-26 |
Cook Medical Technologies Llc |
Medical devices, systems and methods for rapid deployment and fixation of tissue anchors
|
|
CA2758260A1
(en)
*
|
2009-04-08 |
2010-10-14 |
Surmodics, Inc. |
Controlled release devices and methods for delivery of nucleic acids
|
|
AU2010239689A1
(en)
*
|
2009-04-21 |
2011-11-03 |
Selecta Biosciences, Inc. |
Immunonanotherapeutics providing a Th1-biased response
|
|
GB2470378A
(en)
*
|
2009-05-20 |
2010-11-24 |
Univ Westminster |
A controlled release composition for intraocular delivery of a therapeutic agent
|
|
WO2010138193A2
(en)
|
2009-05-27 |
2010-12-02 |
Selecta Biosciences, Inc. |
Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
|
|
US8118777B2
(en)
*
|
2009-05-29 |
2012-02-21 |
Cook Medical Technologies Llc |
Systems and methods for delivering therapeutic agents
|
|
US9101744B2
(en)
|
2009-05-29 |
2015-08-11 |
Cook Medical Technologies Llc |
Systems and methods for delivering therapeutic agents
|
|
US20100324124A1
(en)
*
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Compositions and methods relating to DNA-based particles
|
|
CN107617110A
(zh)
|
2009-08-26 |
2018-01-23 |
西莱克塔生物科技公司 |
诱导t细胞辅助的组合物
|
|
US20110091560A1
(en)
*
|
2009-10-21 |
2011-04-21 |
The Burnham Institute For Medical Research |
Compositions of nanoparticles and methods of making the same
|
|
US8808724B2
(en)
*
|
2009-10-28 |
2014-08-19 |
Ethicon, Inc. |
Antimicrobial coatings with preferred microstructure for medical devices
|
|
CN102811743B
(zh)
|
2009-12-11 |
2015-11-25 |
佰恩德治疗股份有限公司 |
冻干治疗颗粒的稳定制剂
|
|
WO2011072482A1
(en)
*
|
2009-12-14 |
2011-06-23 |
The University Of Hong Kong |
Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells
|
|
JP5965844B2
(ja)
|
2009-12-15 |
2016-08-10 |
バインド セラピューティックス インコーポレイテッド |
高いガラス転移温度または高分子量のコポリマーを有する治療用ポリマーナノ粒子組成物
|
|
GB0922066D0
(en)
|
2009-12-17 |
2010-02-03 |
Univ Belfast |
Modulator
|
|
US8889193B2
(en)
|
2010-02-25 |
2014-11-18 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
|
US20110229556A1
(en)
*
|
2010-03-19 |
2011-09-22 |
Massachusetts Institute Of Technology |
Lipid-coated polymer particles for immune stimulation
|
|
SG184127A1
(en)
|
2010-03-19 |
2012-10-30 |
Massachusetts Inst Technology |
Lipid vesicle compositions and methods of use
|
|
US9149432B2
(en)
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
|
CN107029223A
(zh)
|
2010-05-26 |
2017-08-11 |
西莱克塔生物科技公司 |
合成纳米载体联合疫苗
|
|
US9421240B2
(en)
|
2010-06-22 |
2016-08-23 |
Apellis Pharmaceuticals, Inc. |
Compstatin analogs for treatment of neuropathic pain
|
|
US8865123B1
(en)
|
2010-09-16 |
2014-10-21 |
Mo-Sci Corporation |
Strontium phosphate microparticle for radiological imaging and therapy
|
|
US9119887B2
(en)
|
2010-09-16 |
2015-09-01 |
Mo-Sci Corporation |
Low-density magnesium-aluminum-silicate (MAS) microparticles for radiotherapy and/or radioimaging
|
|
US9849200B2
(en)
|
2010-09-16 |
2017-12-26 |
Mo-Sci Corporation |
Strontium phosphate microparticle for radiological imaging and therapy
|
|
US8740872B2
(en)
|
2010-10-19 |
2014-06-03 |
The Board Of Regents Of The University Of Oklahoma |
Magnetically-targeted treatment for cardiac disorders
|
|
US9744235B2
(en)
|
2010-10-19 |
2017-08-29 |
The Board Of Regents Of The University Of Oklahoma |
Treatment of cardiovascular disorders with targeted nanoparticles
|
|
US10398668B2
(en)
|
2010-10-19 |
2019-09-03 |
The Board Of Regents Of The University Of Oklahoma |
Glutamate treatment of cardiovascular disorders
|
|
EP2630493A4
(en)
|
2010-10-22 |
2014-05-21 |
Univ Florida |
ANTIGEN-SPECIFIC TOLERANCE-INDUCING MICROPARTICLES AND USES THEREOF
|
|
EP2640190A4
(en)
|
2010-11-05 |
2016-05-11 |
Selecta Biosciences Inc |
MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
|
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
|
EP2645991B1
(en)
|
2010-12-02 |
2020-02-12 |
GreenMark Biomedical Inc. |
Aptamer bioconjugate drug delivery device
|
|
US20120148542A1
(en)
|
2010-12-10 |
2012-06-14 |
Lifeline Scientific, Inc. |
Machine perfusion with complement inhibitors
|
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
CA2828253C
(en)
|
2011-02-25 |
2016-10-18 |
South Dakota State University |
Polymer conjugated protein micelles
|
|
BR112013021731A2
(pt)
|
2011-02-25 |
2016-11-01 |
Univ South Dakota |
nanopartícula;composição farmacêutica ou cosmética;utilização; método para melhorar a estabilidade de um retinóide;método para melhorar a dispersibilidade de um retinóide; método para proporcinar a libertação sustentada de um retinóide; método para aumentar a penetração na pele de um retinóide;método para aumentar a acumulação de tumor de encapsulamento de droga;método para reduzir a acumulação de drogas em tecidos de rolamento não tumorais; método para reduzir a toxicidade de um retinóide;método para reduzir a irritação da pele classificação de um retinóide aplicado topicamente encapsulante compreendendo uma pluralidade de nanopartículas;método de preparação de uma nanopartícula
|
|
CN107320734A
(zh)
|
2011-04-29 |
2017-11-07 |
西莱克塔生物科技公司 |
从合成纳米载体中控制释放免疫抑制剂
|
|
JP2014521687A
(ja)
|
2011-07-29 |
2014-08-28 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
US9381112B1
(en)
|
2011-10-06 |
2016-07-05 |
William Eric Sponsell |
Bleb drainage device, ophthalmological product and methods
|
|
US20130142878A1
(en)
*
|
2011-12-01 |
2013-06-06 |
Flow Pharma, Inc. |
Peptide particle formulation
|
|
AU2012318273B2
(en)
*
|
2011-12-02 |
2016-05-19 |
Greenmark Biomedical Inc. |
Aptamer bioconjugate drug delivery device
|
|
US8632489B1
(en)
|
2011-12-22 |
2014-01-21 |
A. Mateen Ahmed |
Implantable medical assembly and methods
|
|
CA2867203C
(en)
|
2012-03-16 |
2016-09-20 |
The Johns Hopkins University |
Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
|
|
US8962577B2
(en)
|
2012-03-16 |
2015-02-24 |
The Johns Hopkins University |
Controlled release formulations for the delivery of HIF-1 inhibitors
|
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
|
WO2013166408A1
(en)
|
2012-05-03 |
2013-11-07 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
US9056057B2
(en)
|
2012-05-03 |
2015-06-16 |
Kala Pharmaceuticals, Inc. |
Nanocrystals, compositions, and methods that aid particle transport in mucus
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
US9533068B2
(en)
|
2012-05-04 |
2017-01-03 |
The Johns Hopkins University |
Drug loaded microfiber sutures for ophthalmic application
|
|
KR102283760B1
(ko)
|
2012-06-21 |
2021-08-03 |
노쓰웨스턴유니버시티 |
펩티드 접합된 입자
|
|
WO2014031883A1
(en)
|
2012-08-23 |
2014-02-27 |
Susan Marie Metcalfe |
Neurotherapeutic nanoparticle compositions and devices
|
|
HUE043998T2
(hu)
|
2012-09-17 |
2019-09-30 |
Pfizer |
Eljárás terápiás nanorészecskék elõállítására
|
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
|
CN111544601A
(zh)
*
|
2012-10-30 |
2020-08-18 |
粒子科学有限公司 |
具有靶向部分的药物递送粒子制剂
|
|
WO2014074952A1
(en)
|
2012-11-09 |
2014-05-15 |
Massachusetts Institute Of Technology |
Methods and compositions for localized delivery of agents to hiv-infected cells and tissues
|
|
US10035822B2
(en)
|
2012-11-15 |
2018-07-31 |
Apellis Pharmaceuticals, Inc. |
Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
|
|
US10568975B2
(en)
|
2013-02-05 |
2020-02-25 |
The Johns Hopkins University |
Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
|
|
US9353122B2
(en)
|
2013-02-15 |
2016-05-31 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
|
US9353123B2
(en)
|
2013-02-20 |
2016-05-31 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
MX382466B
(es)
|
2013-03-13 |
2025-03-13 |
Cour Pharmaceuticals Dev Company |
Partículas inmunomodificadoras para el tratamiento de la inflamación.
|
|
KR102352614B1
(ko)
|
2013-03-14 |
2022-01-18 |
랜 바이오테크놀러지스, 인크. |
생물제제의 검출을 위한 방법 및 물질
|
|
WO2014151836A1
(en)
|
2013-03-14 |
2014-09-25 |
Ran Biotechnologies, Inc. |
Methods and materials for microorganism capture
|
|
US9867931B2
(en)
|
2013-10-02 |
2018-01-16 |
Cook Medical Technologies Llc |
Therapeutic agents for delivery using a catheter and pressure source
|
|
US11931227B2
(en)
|
2013-03-15 |
2024-03-19 |
Cook Medical Technologies Llc |
Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
|
|
WO2014152391A1
(en)
|
2013-03-15 |
2014-09-25 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
WO2014145205A2
(en)
|
2013-03-15 |
2014-09-18 |
St. Jude Children's Research Hospital |
Methods and compositions of p27kip1 transcription modulators
|
|
CN105188667A
(zh)
*
|
2013-03-27 |
2015-12-23 |
佛多斯大学医学研究中心(C·H·U·V) |
用于治疗和/或预防再狭窄的药物制剂
|
|
CA2907915C
(en)
|
2013-04-03 |
2023-03-07 |
Allertein Therapeutics, Llc |
Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
|
|
WO2014176389A1
(en)
*
|
2013-04-24 |
2014-10-30 |
Temple University - Of The Commonwealth System Of Higher Education |
Solid dosage form containing arabinogalactan
|
|
CN105307641A
(zh)
*
|
2013-05-03 |
2016-02-03 |
西莱克塔生物科技公司 |
用于降低不期望体液免疫应答的给药组合
|
|
WO2014179771A1
(en)
*
|
2013-05-03 |
2014-11-06 |
Selecta Biosciences, Inc. |
Dosing combinations for reducing undesired humoral immune responses
|
|
WO2014186435A2
(en)
|
2013-05-14 |
2014-11-20 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for reducing neointima formation
|
|
ES2834129T3
(es)
|
2013-06-04 |
2021-06-16 |
Selecta Biosciences Inc |
Administración repetida de agentes inmunoterapéuticos específicos de antígeno no inmunosupresores
|
|
EP3650038A1
(en)
|
2013-06-19 |
2020-05-13 |
Massachusetts Institute of Technology |
In vivo targeting of cells with ligand-conjugated particles
|
|
DK3033102T4
(da)
|
2013-08-13 |
2024-02-26 |
Univ Northwestern |
Peptidkonjugerede partikler
|
|
WO2015027203A1
(en)
|
2013-08-22 |
2015-02-26 |
Arch Biosurgery, Inc. |
Implantable meshes for controlling the movement of fluids
|
|
CA3191031A1
(en)
|
2013-09-27 |
2015-04-02 |
Massachusetts Institute Of Technology |
Carrier-free biologically-active protein nanostructures
|
|
EP3049154B1
(en)
|
2013-09-29 |
2019-11-13 |
St. Jude Children's Research Hospital, Inc. |
Aryl substituted aminomethyl spectinomycin analogs as antibacterial agents
|
|
US20170080093A1
(en)
*
|
2013-10-22 |
2017-03-23 |
Tyme, Inc. |
Tyrosine Derivatives And Compositions Comprising Them
|
|
US9585841B2
(en)
*
|
2013-10-22 |
2017-03-07 |
Tyme, Inc. |
Tyrosine derivatives and compositions comprising them
|
|
KR20190126452A
(ko)
|
2013-11-01 |
2019-11-11 |
예일 유니버시티 |
면역요법용 모듈러 입자
|
|
KR20160099084A
(ko)
|
2013-11-01 |
2016-08-19 |
칼라 파마슈티컬스, 인크. |
치료 화합물의 결정질 형태 및 그의 용도
|
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
SG10201803780UA
(en)
|
2013-11-04 |
2018-06-28 |
Uti Lp |
Methods and compositions for sustained immunotherapy
|
|
EP3074047A2
(en)
*
|
2013-11-26 |
2016-10-05 |
The Brigham and Women's Hospital, Inc. |
Receptor-targeted nanoparticles for enhanced transcytosis mediated drug delivery
|
|
EP3116547B1
(en)
|
2014-03-14 |
2019-06-05 |
Pfizer Inc |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
|
|
RU2728703C2
(ru)
|
2014-05-02 |
2020-07-31 |
Рисерч Инститьют Эт Нэшнуайд Чилдрен`С Хоспитал |
Композиции и способы для анти-lyst иммуномодуляции
|
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
|
EP3721875B1
(en)
|
2014-05-09 |
2023-11-08 |
Yale University |
Particles coated with hyperbranched polyglycerol and methods for their preparation
|
|
US10898593B2
(en)
*
|
2014-05-13 |
2021-01-26 |
Yale University |
Compositions for nanoconfinement induced contrast enhancement and methods of making and using thereof
|
|
CA2952121A1
(en)
|
2014-06-13 |
2015-12-17 |
Childrens' Medical Center Corporation |
Products and methods to isolate mitochondria
|
|
EP3160453A1
(en)
|
2014-06-25 |
2017-05-03 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
|
EA201790551A1
(ru)
|
2014-09-07 |
2017-07-31 |
Селекта Байосайенсиз, Инк. |
Способы и композиции для ослабления иммунных ответов к пропускающему экзон вирусному трансферному вектору
|
|
US10232050B1
(en)
|
2014-12-12 |
2019-03-19 |
Clemson University |
Multi-functional particles and methods of using the same
|
|
US11633355B2
(en)
|
2014-12-12 |
2023-04-25 |
Clemson University Research Foundation |
Multi-functional particles and methods of using the same
|
|
CN107427604B
(zh)
|
2015-01-16 |
2021-07-09 |
脊柱康健公司 |
治疗椎间盘的方法
|
|
JP6846351B2
(ja)
|
2015-01-27 |
2021-03-24 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤
|
|
WO2016172183A1
(en)
|
2015-04-21 |
2016-10-27 |
Ran Biotechnologies, Inc. |
Novel fluorinated surfactants
|
|
ES3055030T3
(en)
|
2015-05-06 |
2026-02-09 |
Uti Lp |
Nanoparticle compositions for sustained therapy
|
|
US10385311B2
(en)
*
|
2015-05-27 |
2019-08-20 |
Purdue Research Foundation |
Method of making biological tissue components
|
|
CN108137595B
(zh)
|
2015-06-18 |
2021-04-20 |
听治疗有限责任公司 |
预防和治疗听力损失的方法和组合物
|
|
AU2016305087B2
(en)
|
2015-08-12 |
2022-01-20 |
Massachusetts Institute Of Technology |
Cell surface coupling of nanoparticles
|
|
KR20180090785A
(ko)
|
2015-10-07 |
2018-08-13 |
아펠리스 파마슈티컬스 인코포레이티드 |
투여 요법
|
|
CN105363071B
(zh)
*
|
2015-11-23 |
2018-10-09 |
金仕生物科技（常熟）有限公司 |
生物材料的抗钙化处理方法
|
|
US20170151287A1
(en)
|
2015-11-30 |
2017-06-01 |
Flagship Ventures Management, Inc. |
Methods and compositions of chondrisomes
|
|
WO2017096262A1
(en)
|
2015-12-04 |
2017-06-08 |
Jomoco, Corp. |
Compositions and methods to mitigate or prevent an immune response to an immunogenic therapeutic molecule in non-human primates
|
|
EP3389720A1
(en)
|
2015-12-18 |
2018-10-24 |
The General Hospital Corporation |
Polyacetal polymers, conjugates, particles and uses thereof
|
|
ES3057779T3
(en)
|
2016-01-15 |
2026-03-04 |
Childrens Medical Ct Corp |
Therapeutic use of mitochondria and combined mitochondrial agents
|
|
AU2017221424A1
(en)
|
2016-02-16 |
2018-09-20 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
|
JP2019508037A
(ja)
|
2016-02-16 |
2019-03-28 |
イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔ |
標的化遺伝子編集を増強するための組成物およびその使用方法
|
|
RS65941B1
(sr)
|
2016-03-11 |
2024-10-31 |
Cartesian Therapeutics Inc |
Formulacije i doze pegilovane urikaze
|
|
WO2017172769A1
(en)
*
|
2016-03-28 |
2017-10-05 |
The Johns Hopkins University |
Biomimetic anisotropic polymeric particles with naturally derived cell membranes for enhanced drug delivery
|
|
SG11201808528VA
(en)
*
|
2016-03-30 |
2018-10-30 |
Convatec Technologies Inc |
Modified wound dressings
|
|
WO2017190145A1
(en)
|
2016-04-29 |
2017-11-02 |
Icahn School Of Medicine At Mount Sinai |
Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis
|
|
CN109715196A
(zh)
|
2016-06-13 |
2019-05-03 |
转矩医疗股份有限公司 |
用于促进免疫细胞功能的组合物和方法
|
|
US10253036B2
(en)
|
2016-09-08 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
WO2018048750A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
EP3509421A4
(en)
|
2016-09-08 |
2020-05-20 |
Kala Pharmaceuticals, Inc. |
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF
|
|
CN109922819A
(zh)
|
2016-09-27 |
2019-06-21 |
西莱克塔生物科技公司 |
用于治疗癌症的重组免疫毒素
|
|
WO2018089688A1
(en)
|
2016-11-09 |
2018-05-17 |
Jinjun Shi |
Restoration of tumor suppression using mrna-based delivery system
|
|
US11559606B2
(en)
|
2016-12-09 |
2023-01-24 |
The Penn State Research Foundation |
Semi-synthetic tissue constructs for tissue regeneration
|
|
JP2020506890A
(ja)
|
2017-01-07 |
2020-03-05 |
セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． |
合成ナノキャリアにカップリングした免疫抑制剤のパターン化された投与
|
|
EP4599848A3
(en)
|
2017-03-11 |
2025-12-03 |
Cartesian Therapeutics, Inc. |
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
|
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
|
BR112019020955A2
(pt)
|
2017-04-07 |
2020-05-05 |
Apellis Pharmaceuticals, Inc. |
regimes de dosagem e composições e métodos relacionados
|
|
US11576872B2
(en)
|
2017-05-08 |
2023-02-14 |
Flagship Pioneering Innovations V, Inc. |
Compositions for facilitating membrane fusion and uses thereof
|
|
CA3063508A1
(en)
|
2017-05-26 |
2018-11-29 |
Holly H. Ganz |
Products and methods for therapeutic administration of microorganisms to non-human animals
|
|
US20180355121A1
(en)
*
|
2017-06-13 |
2018-12-13 |
Uvic Industry Partnerships Inc. |
Multifunctional microcarriers with thermo-responsive biomaterial coating and use thereof
|
|
CA3066750A1
(en)
|
2017-06-13 |
2018-12-20 |
Flagship Pioneering Innovations V, Inc. |
Compositions comprising curons and uses thereof
|
|
CA3074826A1
(en)
|
2017-09-05 |
2019-03-14 |
Torque Therapeutics, Inc. |
Therapeutic protein compositions and methods of making and using the same
|
|
WO2019075360A1
(en)
|
2017-10-13 |
2019-04-18 |
Selecta Biosciences, Inc. |
METHODS AND COMPOSITIONS FOR MITIGATING ANTI-VECTOR VIRAL TRANSFER IGM RESPONSES
|
|
EP3716949A4
(en)
|
2017-11-29 |
2022-05-18 |
UTI Limited Partnership |
METHODS OF TREATMENT OF AUTOIMMUNE DISEASES
|
|
JP2021507884A
(ja)
|
2017-12-15 |
2021-02-25 |
アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
投与レジメンならびに関連組成物および方法
|
|
CN108175864A
(zh)
*
|
2018-01-12 |
2018-06-19 |
中山大学 |
一种多模态成像纳米探针及其合成方法
|
|
CN111918675A
(zh)
|
2018-03-28 |
2020-11-10 |
格林马克生物医药股份有限公司 |
磷酸盐交联淀粉纳米颗粒和牙科治疗
|
|
CN111989068B
(zh)
|
2018-05-24 |
2024-10-25 |
塞拉尼斯伊娃高性能聚合物公司 |
用于持续释放大分子药物化合物的可植入器件
|
|
CA3087238A1
(en)
|
2018-05-24 |
2019-11-28 |
Celanese EVA Performance Polymers Corporation |
Implantable device for sustained release of a macromolecular drug compound
|
|
EP3803866A4
(en)
|
2018-05-24 |
2022-03-16 |
Nureva Inc. |
METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
|
|
EP3823676A1
(en)
|
2018-07-16 |
2021-05-26 |
Selecta Biosciences, Inc. |
Methods and compositions of mma constructs and vectors
|
|
CN112771070A
(zh)
|
2018-07-16 |
2021-05-07 |
西莱克塔生物科技公司 |
Otc构建体和载体的方法和组合物
|
|
US20210189431A1
(en)
|
2018-08-10 |
2021-06-24 |
Yale University |
Compositions and methods for embryonic gene editing in vitro
|
|
CN118033116A
(zh)
*
|
2018-08-15 |
2024-05-14 |
苏州尔生生物医药有限公司 |
用于抗原特异性t细胞含量检测的检测纳米颗粒、检测方法及试剂盒
|
|
WO2020146031A1
(en)
*
|
2018-10-18 |
2020-07-16 |
The Regents Of The University Of California |
Methods for fabricating modular hydrogels from macromolecules with orthogonal physico-chemical responsivity
|
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
|
CA3121528A1
(en)
|
2018-12-12 |
2020-06-18 |
Flagship Pioneering Innovations V, Inc. |
Anellosomes and methods of use
|
|
WO2020210805A1
(en)
|
2019-04-11 |
2020-10-15 |
The Johns Hopkins University |
Nanoparticles for drug delivery to brain
|
|
CA3138525A1
(en)
|
2019-04-28 |
2020-11-05 |
Selecta Biosciences, Inc. |
Methods for treatment of subjects with preexisting immunity to viral transfer vectors
|
|
CA3141863A1
(en)
|
2019-05-28 |
2020-12-03 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuated anti-viral transfer vector immune response
|
|
US12553041B2
(en)
|
2019-06-04 |
2026-02-17 |
Cartesian Therapeutics Inc. |
Formulations and doses of pegylated uricase
|
|
US20220372474A1
(en)
|
2019-06-21 |
2022-11-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
|
CN110221081B
(zh)
*
|
2019-06-26 |
2023-01-24 |
上海执诚生物科技有限公司 |
视黄醇结合蛋白胶乳试剂r2及其制备方法和试剂盒
|
|
US12648567B2
(en)
|
2019-07-11 |
2026-06-09 |
Newleaf Symbiotics, Inc. |
Microbial compositions
|
|
US12496357B2
(en)
|
2019-07-31 |
2025-12-16 |
Yale University |
Compositions and methods for treating sickle cell disease
|
|
EP4025698A1
(en)
|
2019-09-03 |
2022-07-13 |
Sana Biotechnology, Inc. |
Cd24-associated particles and related methods and uses thereof
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
US20210154324A1
(en)
|
2019-10-21 |
2021-05-27 |
Selecta Biosciences, Inc. |
Methods and compositions for treating liver diseases and disorders
|
|
IL292770A
(en)
|
2019-11-08 |
2022-07-01 |
Selecta Biosciences Inc |
Formulations and dosages of polyethylene glycol-modified oricase
|
|
EP4106828B1
(en)
|
2020-02-21 |
2026-03-11 |
Tonic Medical, Inc. |
Polymer-encapsulated drug particles
|
|
MX2022010568A
(es)
|
2020-02-26 |
2022-11-30 |
Selecta Biosciences Inc |
Métodos y composiciones que usan nanoportadores sintéticos que comprenden inmunosupresor.
|
|
KR20230002613A
(ko)
|
2020-04-14 |
2023-01-05 |
셀렉타 바이오사이언시즈, 인크. |
자가포식을 유도하기 위한 방법 및 조성물
|
|
BR112022023464A2
(pt)
|
2020-06-05 |
2022-12-20 |
Cook Medical Technologies Llc |
Endoscópios médicos para entregar agentes terapêuticos
|
|
US20230248652A1
(en)
*
|
2020-06-16 |
2023-08-10 |
Oxford University Innovation Limited |
Biodegradeable multi-cavity microparticles and their use in treatment
|
|
EP4209229A4
(en)
|
2020-09-04 |
2024-07-31 |
Osaka University |
LIPOSOME PREPARATION WITH ANTIBACTERIAL ACTIVE INGREDIENT
|
|
WO2022084929A1
(en)
*
|
2020-10-23 |
2022-04-28 |
Universita' Degli Studi Di Modena E Reggio Emilia |
Nanoparticles for transport across the blood-brain barrier
|
|
MX2023005224A
(es)
|
2020-11-04 |
2023-07-18 |
Selecta Biosciences Inc |
Composiciones para reducir las respuestas inmunes contra inmunoglobulina proteasas.
|
|
AU2022206197A1
(en)
|
2021-01-05 |
2023-07-13 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
|
CN118459539B
(zh)
|
2021-03-19 |
2026-01-06 |
生物治疗探索股份有限公司 |
用于调节训练免疫的化合物及其使用方法
|
|
KR20230167405A
(ko)
|
2021-04-09 |
2023-12-08 |
셀렉타 바이오사이언시즈, 인크. |
면역 관용을 증진시키기 위해 고친화도 il-2 수용체 효능제와 조합된 면역억제제를 포함하는 합성 나노담체
|
|
EP4329734A4
(en)
|
2021-04-26 |
2025-04-02 |
Celanese EVA Performance Polymers LLC |
Implantable device for the delayed release of a macromolecular drug compound
|
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
|
WO2023287654A1
(en)
|
2021-07-14 |
2023-01-19 |
Cook Medical Technologies, LLC |
Systems and methods for preventing clogging of a delivery system
|
|
US20230140196A1
(en)
|
2021-10-12 |
2023-05-04 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
|
US20230141563A1
(en)
|
2021-10-12 |
2023-05-11 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
|
US12201643B2
(en)
|
2021-10-15 |
2025-01-21 |
The Board Of Trustees Of The University Of Illinois |
Mechanochemical dynamic for focal cancer treatment
|
|
WO2023086615A1
(en)
|
2021-11-14 |
2023-05-19 |
Selecta Biosciences, Inc. |
Multiple dosing with viral vectors
|
|
US20230263906A1
(en)
|
2022-01-10 |
2023-08-24 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing
|
|
WO2023172628A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosing
|
|
US20230357437A1
(en)
|
2022-03-09 |
2023-11-09 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
|
WO2023183568A1
(en)
|
2022-03-25 |
2023-09-28 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists and anti-igm agents
|
|
WO2023196566A1
(en)
|
2022-04-08 |
2023-10-12 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance
|
|
JP2025526816A
(ja)
|
2022-08-11 |
2025-08-15 |
カーティザン セラピューティクス，インコーポレーテッド |
免疫グロブリンプロテアーゼおよびその融合体に関する組成物および方法
|
|
US12496429B2
(en)
|
2022-10-18 |
2025-12-16 |
Cook Medical Technologies Llc |
Systems and methods for delivering pressurized fluid to a target site alone or in conjunction with therapeutic agents
|
|
WO2024107889A1
(en)
|
2022-11-15 |
2024-05-23 |
Selecta Biosciences, Inc. |
Compositions and methods for treating primary biliary cholangitis
|
|
EP4687768A2
(en)
|
2023-04-06 |
2026-02-11 |
33 Medical, Inc. |
Minimally invasive compliant devices for total lumbar disc replacement
|
|
WO2024229370A1
(en)
|
2023-05-03 |
2024-11-07 |
Cartesian Therapeutics, Inc. |
Compositions and methods for treating gvhd
|
|
WO2024229380A1
(en)
|
2023-05-03 |
2024-11-07 |
Cartesian Therapeutics, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists in autoimmune liver diseases
|
|
WO2024229350A1
(en)
|
2023-05-03 |
2024-11-07 |
Cartesian Therapeutics, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists for diabetes
|
|
WO2024229432A1
(en)
|
2023-05-03 |
2024-11-07 |
Cartesian Therapeutics, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists to enhance immune tolerance
|
|
GB202307563D0
(en)
|
2023-05-19 |
2023-07-05 |
Univ King Abdullah Sci & Tech |
Methods and compositions
|
|
KR20260021016A
(ko)
|
2023-06-02 |
2026-02-12 |
33 메디칼, 인크. |
추간판성 통증의 치료를 위한 조성물, 및 그의 제조 및 사용 방법
|
|
WO2025024693A1
(en)
|
2023-07-25 |
2025-01-30 |
Massachusetts Institute Of Technology |
Compositions and methods for treating fan1 associated trinucleotide repeat expansion disorders
|
|
CN122124183B
(zh)
*
|
2026-05-06 |
2026-07-17 |
鄂尔多斯市蒙医医院(鄂尔多斯市蒙医研究所) |
一种额尔敦-7颗粒药剂及其制备方法
|